ArticleBMC pulmonary medicine2023

Low human beta-defensin-2 levels in the sputum of COPD patients are associated with the risk of exacerbations.

Shengchuan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.